Melanoma Coverage from Every Angle

Anthony J. Olszanski, RPh, MD, and John A. Thompson, MD, on Advanced Melanoma: Novel Treatment Approaches in Two Settings

Posted: Friday, March 30, 2018

Anthony J. Olszanski, RPh, MD, of Fox Chase Cancer Center, and John A. Thompson, MD, of the University of Washington Fred Hutchinson Cancer Research Center, discuss findings from two studies: dabrafenib and trametinib in patients with BRAF V600–mutant melanoma brain metastases; and talimogene laherparepvec and ipilimumab vs ipilimumab alone in unresected stage IIIB–IV melanoma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.